RGL2 and colorectal carcinoma: Moreover, another Kaplan-Meier analysis of RLG2 protein levels determined by IHC experiments (Figure 2D) demonstrated that higher protein expression of RGL2 indicates a poorer overall survival probability in CRC patients enrolled in a commercial tissue microarray (Figure 2E).